These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fluorinated MRI contrast agents and their versatile applications in the biomedical field. Hequet E; Henoumont C; Muller RN; Laurent S Future Med Chem; 2019 May; 11(10):1157-1175. PubMed ID: 31280670 [TBL] [Abstract][Full Text] [Related]
5. A Hyperfluorinated Hydrophilic Molecule for Aqueous Tanifum EA; Devkota L; Ngwa C; Badachhape AA; Ghaghada KB; Romero J; Pautler RG; Annapragada AV Contrast Media Mol Imaging; 2018; 2018():1693513. PubMed ID: 30538612 [TBL] [Abstract][Full Text] [Related]
6. Perfluorocarbons-Based Wu L; Liu F; Liu S; Xu X; Liu Z; Sun X Int J Nanomedicine; 2020; 15():7377-7395. PubMed ID: 33061385 [TBL] [Abstract][Full Text] [Related]
8. Spontaneous Nucleation of Stable Perfluorocarbon Emulsions for Ultrasound Contrast Agents. Li DS; Schneewind S; Bruce M; Khaing Z; O'Donnell M; Pozzo L Nano Lett; 2019 Jan; 19(1):173-181. PubMed ID: 30543289 [TBL] [Abstract][Full Text] [Related]
9. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Flögel U; Ding Z; Hardung H; Jander S; Reichmann G; Jacoby C; Schubert R; Schrader J Circulation; 2008 Jul; 118(2):140-8. PubMed ID: 18574049 [TBL] [Abstract][Full Text] [Related]
10. Echogenicity enhancement by end-fluorinated polylactide perfluorohexane nanocapsules: Towards ultrasound-activable nanosystems. Picheth G; Houvenagel S; Dejean C; Couture O; Alves de Freitas R; Moine L; Tsapis N Acta Biomater; 2017 Dec; 64():313-322. PubMed ID: 28986300 [TBL] [Abstract][Full Text] [Related]
11. Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half-lives and sensitivity. Jacoby C; Temme S; Mayenfels F; Benoit N; Krafft MP; Schubert R; Schrader J; Flögel U NMR Biomed; 2014 Mar; 27(3):261-71. PubMed ID: 24353148 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive Imaging of Early Venous Thrombosis by 19F Magnetic Resonance Imaging With Targeted Perfluorocarbon Nanoemulsions. Temme S; Grapentin C; Quast C; Jacoby C; Grandoch M; Ding Z; Owenier C; Mayenfels F; Fischer JW; Schubert R; Schrader J; Flögel U Circulation; 2015 Apr; 131(16):1405-14. PubMed ID: 25700177 [TBL] [Abstract][Full Text] [Related]
13. Perfluorocarbons in Research and Clinical Practice: A Narrative Review. Nocentini G; MacLaren G; Bartlett R; De Luca D; Perdichizzi S; Stoppa F; Marano M; Cecchetti C; Biasucci DG; Polito A; AlGhobaishi A; Guner Y; Gowda SH; Hirschl RB; Di Nardo M ASAIO J; 2023 Dec; 69(12):1039-1048. PubMed ID: 37549675 [TBL] [Abstract][Full Text] [Related]
14. Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons. Sheeran PS; Luois SH; Mullin LB; Matsunaga TO; Dayton PA Biomaterials; 2012 Apr; 33(11):3262-9. PubMed ID: 22289265 [TBL] [Abstract][Full Text] [Related]
15. A fluorinated dendrimer-based nanotechnology platform: new contrast agents for high field imaging. Huang Z; Sengar RS; Nigam A; Abadjian MC; Potter DM; Grotjahn DB; Wiener EC Invest Radiol; 2010 Oct; 45(10):641-54. PubMed ID: 20856012 [TBL] [Abstract][Full Text] [Related]
20. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery. Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]